Skip to main content

TherapeuticsMD, Inc.

corporate_fare Company Profile

TherapeuticsMD, Inc.

TXMD·NASDAQ·Healthcare·CIK 0000025743

TherapeuticsMD is a pharmaceutical royalty company that owns or has rights to trademarks, service marks, or trade names. These intellectual properties were previously used in connection with the operation of its business or are now licensed by another party. The company's wholly-owned subsidiaries include vitaMedMD, LLC and BocaGreenMD, Inc. Key trademarks owned by TherapeuticsMD include TherapeuticsMD®, vitaMedMD®, BocaGreenMD®, BIJUVA®, and IMVEXXY®. These are protected under applicable intellectual property laws and are the property of the Company.

TherapeuticsMD, Inc. (NASDAQ:TXMD) is a publicly traded company in the Healthcare sector. Wiseek monitors TXMD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • TherapeuticsMD Reports Q1 Profit and Increased Cash, but Discloses Substantial Doubt About Going Concern
  • TherapeuticsMD Explores Sale or Merger After Swinging to Q1 Net Income
  • TherapeuticsMD Reports Q1 2026 Net Income and Increased License Revenue
  • TherapeuticsMD Reports Strong 2025 Financials, Actively Explores Strategic Alternatives
  • TherapeuticsMD Reports Strong 2025: License Revenue Jumps 71.6%, Net Loss Significantly Narrows

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.02M
Net Income
-$569K
Diluted EPS
-$0.05
Operating Income
-$4.39M
Cash & Equivalents
$7.48M
Debt / Equity
0.00×
Net Margin
-18.8%
Shares Outstanding
11.57M sh
Source: 10-K · filed 2026-04-01 · accession 0001213900-26-037918
$2.16 -0.04% today
52-week range · as of 2026-05-12 $0.9811 – $2.95
Market cap
$25.46M
Volume
260K (5.6× avg)
3-mo avg 46.3K
Live data · 2026-06-14 07:43 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TXMD - Latest Insights

TXMD
May 12, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
TherapeuticsMD Reports Q1 Profit and Increased Cash, but Discloses Substantial Doubt About Going Concern
Price at Filing: $1.94
Real-time Price: $2.16 info
Change: +$0.2203 (+11%) info
Market Cap: $25.464M info
Sentiment: Negative
View Wiseek Article
TXMD
May 12, 2026, 4:13 PM EDT
Source: Reuters
Importance Score:
9
TherapeuticsMD Explores Sale or Merger After Swinging to Q1 Net Income
Price at Filing: $1.95
Real-time Price: $2.16 info
Change: +$0.2103 (+11%) info
Market Cap: $25.464M info
Sentiment: Positive
View Wiseek Article
TXMD
May 12, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
TherapeuticsMD Reports Q1 2026 Net Income and Increased License Revenue
Price at Filing: $1.95
Real-time Price: $2.16 info
Change: +$0.2103 (+11%) info
Market Cap: $25.464M info
Sentiment: Positive
View Wiseek Article
TXMD
Mar 30, 2026, 5:56 PM EDT
Filing Type: 8-K
Importance Score:
8
TherapeuticsMD Reports Strong 2025 Financials, Actively Explores Strategic Alternatives
Price at Filing: $1.99
Real-time Price: $2.16 info
Change: +$0.1703 (+9%) info
Market Cap: $25.464M info
Sentiment: Positive
View Wiseek Article
TXMD
Mar 30, 2026, 5:45 PM EDT
Source: Wiseek News
Importance Score:
8
TherapeuticsMD Reports Strong 2025: License Revenue Jumps 71.6%, Net Loss Significantly Narrows
Price at Filing: $1.99
Real-time Price: $2.16 info
Change: +$0.1703 (+9%) info
Market Cap: $25.464M info
Sentiment: Positive
View Wiseek Article